CXCL-10 antibody (Stelic Institute)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCXCL-10 antibody (Stelic Institute)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStelic Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStelic Institute
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A